CHEK2 Gene Mutation Clinical Trials

9 clinical trials for CHEK2 Gene Mutation across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. — RECRUITING
• An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results — RECRUITING · NA
• Video Capsule Examination in Patients With Lynch Syndrome — RECRUITING · NA
• Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects — TERMINATED · PHASE2
• Niraparib, Abiraterone Acetate and Prednisone for mHSPC With Deleterious Homologous Recombination Repair Alterations — WITHDRAWN · PHASE2
• Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer — NOT_YET_RECRUITING · PHASE2
• Olaparib In Metastatic Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion — ACTIVE_NOT_RECRUITING · PHASE2
• Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer — COMPLETED · PHASE2

Refine this search